https://www.freep.com/story/news/health/2020/08/13/henry-ford-health-hydroxychloroquine-covid-fda/3360940001/August 13th.
"
FDA denies Henry Ford Health request to use hydroxychloroquine for COVID-19 patientsKristen Jordan Shamus
Detroit Free Press
Aug, 13, 2020
Weeks after the U.S. Food and Drug Administration revoked emergency use authorization of hydroxychloroquine to treat COVID-19, saying the drug doesn't help coronavirus patients and has potentially dangerous side effects, Henry Ford Health System filed for permission to continue using it.
The Detroit-based health system told the Free Press this week that it sought emergency use authorization July 6 to resume treating some COVID-19 patients with the drug, which is commonly used as an anti-malarial medication and for people with autoimmune diseases like lupus.
The request came four days after Henry Ford published a controversial study in the International Journal of Infectious Diseases that suggested hydroxychloroquine slashed the COVID-19 death rate in half. The peer-reviewed observational study contradicted other published reports that showed the drug doesn't help coronavirus patients and could cause heart rhythm problems in some people.
The FDA denied Henry Ford's request this week.
"The U.S. Food and Drug Administration informed us that it would not grant our request for an emergency use authorization for hydroxychloroquine for a segment of COVID-19 patients meeting very specific criteria," said Dr. Adnan Munkarah, Henry Ford's executive vice president and chief clinical officer, in a statement.
The patients who would have received the drug would have had to meet the same criteria as those who were enrolled in Henry Ford's initial study:
Age 18 or older
Have a positive COVID-19 test
Be admitted to any of its six hospitals
Be low risk for heart complications based on an electrocardiogram algorithm. A QT interval higher than 500 milliseconds was considered an elevated cardiac risk.
Henry Ford's study was widely criticized because it was observational, retrospective and not randomized or controlled. Additionally, the health system used hydroxychloroquine in combination with dexamethasone, a steroid, which has been known to improve outcomes for people with COVID-19."
much much more with video
https://www.freep.com/story/news/health/2020/08/13/henry-ford-health-hydroxychloroquine-covid-fda/3360940001/So the FDA inserts itself between doctors and patients denying a cure that Henry Ford Health found reduced COVID mortality by 50%. How does that not constitute a crime against humanity and homicide? Particularly heinous as the
FDA once again positively proves itself the lapdog of Big Pharma since it still hasn't revoked EUA for Remdesivir when:
"A large study sponsored by the World Health Organization found that remdesivir doesn’t help hospitalized patients with COVID-19 survive and doesn’t even shorten the recovery time of those who do survive.", yet Remdesivir's side effects include heart, liver and kidney damage. So dangerous, experimental, Remdesivir remains what the FDA gives its emergency use authorization to, that keeps it within the "standard of care"! A drug that costs from $3,200 (to $6,400 I presume for the 10 day course), per patient that "doesn’t help hospitalized patients with COVID-19" and has ugly side effects, when
Henry Ford found a 51% reduction in mortality with hydroxychloroquine even in the early
INpatient hospital setting, and they didn't even use zinc, while using Azithromycin in synergy with HCQ on only part of the patients.
https://www.covid-19forum.org/index.php?topic=120.0How does this not constitute killing Henry Ford's patients with malice, since the FDA already knows that Henry Ford Hospital previously realized a 50% reduction in mortality from using HCQ, while the new WHO report finds Remdesivir to be comparatively worthless?
https://www.covid-19forum.org/index.php?topic=366.0Let alone that by now the FDA cannot plead ignorance in regard to the doctors in the U.S. that have had 99-100% success ever since March, using HCQ+Z+AZ in the early outpatient setting when administered immediately upon the presentation of symptoms or clinical suspicion of COVID-19.
https://www.covid-19forum.org/index.php?board=3.0
